| positive regulation of necrotic cell death | GO:0010940 | 4 | 0.935 | |
| regulation of insulin secretion | GO:0050796 | 33 | 0.926 | |
| positive regulation of transport | GO:0051050 | 336 | 0.886 | |
| actin filament based process | GO:0030029 | 224 | 0.872 | Human |
| actin filament organization | GO:0007015 | 128 | 0.706 | |
| negative regulation of voltage gated calcium channel activity | GO:1901386 | 4 | 0.685 | |
| ribonucleotide catabolic process | GO:0009261 | 405 | 0.674 | |
| regulation of secretion by cell | GO:1903530 | 177 | 0.651 | |
| regulation of cellular component biogenesis | GO:0044087 | 281 | 0.644 | |
| nucleotide catabolic process | GO:0009166 | 408 | 0.641 | |
| negative regulation of apoptotic process | GO:0043066 | 316 | 0.611 | |
| hormone secretion | GO:0046879 | 65 | 0.600 | |
| somatic stem cell division | GO:0048103 | 1 | 0.596 | |
| regulation of actin filament based process | GO:0032970 | 141 | 0.594 | Human |
| protein autoprocessing | GO:0016540 | 4 | 0.579 | |
| nuclear migration | GO:0007097 | 1 | 0.578 | |
| nitrogen compound transport | GO:0071705 | 191 | 0.570 | |
| secretion | GO:0046903 | 254 | 0.547 | |
| organophosphate catabolic process | GO:0046434 | 430 | 0.536 | |
| inorganic ion transmembrane transport | GO:0098660 | 231 | 0.530 | Human |
| stem cell division | GO:0017145 | 2 | 0.521 | |
| oogenesis | GO:0048477 | 2 | 0.514 | |
| purine nucleoside catabolic process | GO:0006152 | 398 | 0.513 | |
| ribonucleoside catabolic process | GO:0042454 | 406 | 0.498 | |
| cell cell signaling | GO:0007267 | 155 | 0.493 | |
| signal release | GO:0023061 | 70 | 0.484 | |
| glucose transport | GO:0015758 | 30 | 0.478 | |
| neuronal stem cell division | GO:0036445 | 1 | 0.476 | |
| regulation of hormone secretion | GO:0046883 | 57 | 0.473 | |
| regulation of hormone levels | GO:0010817 | 125 | 0.466 | |
| actin cytoskeleton organization | GO:0030036 | 207 | 0.454 | |
| regulation of actin filament polymerization | GO:0030833 | 50 | 0.453 | |
| protein localization to organelle | GO:0033365 | 280 | 0.449 | |
| anterograde axon cargo transport | GO:0008089 | 1 | 0.447 | |
| secretion by cell | GO:0032940 | 226 | 0.443 | |
| purine nucleoside triphosphate catabolic process | GO:0009146 | 392 | 0.439 | |
| establishment of nucleus localization | GO:0040023 | 1 | 0.432 | |
| cell adhesion | GO:0007155 | 325 | 0.430 | |
| ribonucleoside triphosphate metabolic process | GO:0009199 | 412 | 0.415 | |
| protein glycosylation | GO:0006486 | 62 | 0.403 | |
| positive regulation of secretion by cell | GO:1903532 | 108 | 0.390 | |
| negative regulation of protein modification process | GO:0031400 | 200 | 0.386 | |
| gtp catabolic process | GO:0006184 | 237 | 0.385 | |
| nucleoside triphosphate metabolic process | GO:0009141 | 422 | 0.375 | |
| purine nucleoside triphosphate metabolic process | GO:0009144 | 412 | 0.372 | |
| syncytium formation by plasma membrane fusion | GO:0000768 | 2 | 0.368 | |
| regulation of peptide transport | GO:0090087 | 62 | 0.366 | |
| negative regulation of transport | GO:0051051 | 176 | 0.364 | Human |
| post embryonic development | GO:0009791 | 2 | 0.360 | |
| regulation of secretion | GO:0051046 | 194 | 0.346 | |
| purine ribonucleoside catabolic process | GO:0046130 | 398 | 0.337 | |
| protein targeting | GO:0006605 | 187 | 0.331 | |
| inorganic cation transmembrane transport | GO:0098662 | 194 | 0.330 | Human |
| peptide transport | GO:0015833 | 74 | 0.329 | |
| blastocyst development | GO:0001824 | 3 | 0.319 | |
| regulation of necrotic cell death | GO:0010939 | 9 | 0.318 | |
| regulation of actin filament length | GO:0030832 | 56 | 0.307 | |
| negative regulation of cell death | GO:0060548 | 345 | 0.306 | |
| type b pancreatic cell apoptotic process | GO:0097050 | 5 | 0.305 | |
| cellular protein complex assembly | GO:0043623 | 188 | 0.301 | |
| purine ribonucleotide catabolic process | GO:0009154 | 404 | 0.300 | |
| female gamete generation | GO:0007292 | 2 | 0.298 | |
| positive regulation of glucose transport | GO:0010828 | 17 | 0.297 | |
| protein maturation | GO:0051604 | 233 | 0.295 | |
| purine ribonucleoside metabolic process | GO:0046128 | 437 | 0.291 | |
| circulatory system development | GO:0072359 | 262 | 0.286 | |
| neuroblast proliferation | GO:0007405 | 4 | 0.283 | |
| positive regulation of peptide secretion | GO:0002793 | 15 | 0.283 | |
| nucleoside triphosphate catabolic process | GO:0009143 | 394 | 0.280 | |
| embryo development | GO:0009790 | 123 | 0.279 | |
| positive regulation of insulin secretion | GO:0032024 | 10 | 0.278 | |
| nucleoside phosphate catabolic process | GO:1901292 | 412 | 0.263 | |
| hormone transport | GO:0009914 | 68 | 0.262 | |
| protein polymerization | GO:0051258 | 71 | 0.261 | |
| establishment or maintenance of apical basal cell polarity | GO:0035088 | 2 | 0.255 | |
| regulation of gtp catabolic process | GO:0033124 | 180 | 0.251 | |
| wnt signaling pathway | GO:0016055 | 156 | 0.251 | |
| nucleoside catabolic process | GO:0009164 | 408 | 0.241 | |
| purine containing compound catabolic process | GO:0072523 | 411 | 0.239 | |
| multicellular organismal aging | GO:0010259 | 3 | 0.226 | |
| anatomical structure formation involved in morphogenesis | GO:0048646 | 284 | 0.226 | |
| cell projection assembly | GO:0030031 | 126 | 0.222 | |
| amide transport | GO:0042886 | 76 | 0.222 | |
| positive regulation of cellular amine metabolic process | GO:0033240 | 7 | 0.217 | |
| cell division | GO:0051301 | 168 | 0.217 | |
| glucose import | GO:0046323 | 24 | 0.211 | |
| regulation of actin polymerization or depolymerization | GO:0008064 | 56 | 0.209 | |
| midbrain development | GO:0030901 | 45 | 0.206 | |
| regulation of protein localization | GO:0032880 | 296 | 0.202 | |
| regulation of cellular amino acid metabolic process | GO:0006521 | 6 | 0.196 | |
| actin filament polymerization | GO:0030041 | 45 | 0.194 | |
| oocyte development | GO:0048599 | 1 | 0.191 | |
| ras protein signal transduction | GO:0007265 | 73 | 0.190 | |
| insulin secretion | GO:0030073 | 39 | 0.173 | |
| cation transmembrane transport | GO:0098655 | 238 | 0.170 | Human |
| regulation of transmembrane transport | GO:0034762 | 139 | 0.168 | Human |
| regulation of i kappab kinase nf kappab signaling | GO:0043122 | 162 | 0.168 | |
| positive regulation of cell death | GO:0010942 | 263 | 0.166 | |
| purine nucleotide catabolic process | GO:0006195 | 405 | 0.164 | |
| cellular response to endogenous stimulus | GO:0071495 | 336 | 0.163 | |
| canonical wnt signaling pathway | GO:0060070 | 116 | 0.162 | |
| cellular response to hormone stimulus | GO:0032870 | 125 | 0.162 | |
| neural nucleus development | GO:0048857 | 47 | 0.160 | |
| regulation of anatomical structure size | GO:0090066 | 101 | 0.157 | |
| ion transmembrane transport | GO:0034220 | 338 | 0.156 | Human |
| neuroblast division | GO:0055057 | 1 | 0.155 | |
| purine ribonucleoside triphosphate metabolic process | GO:0009205 | 411 | 0.154 | |
| cellular response to insulin stimulus | GO:0032869 | 41 | 0.154 | |
| purine ribonucleoside triphosphate catabolic process | GO:0009207 | 391 | 0.151 | |
| cell projection organization | GO:0030030 | 252 | 0.151 | |
| single organism cellular localization | GO:1902580 | 332 | 0.150 | |
| positive regulation of peptide hormone secretion | GO:0090277 | 15 | 0.149 | |
| membrane organization | GO:0061024 | 292 | 0.149 | |
| negative regulation of catalytic activity | GO:0043086 | 335 | 0.149 | |
| thiamine transmembrane transport | GO:0071934 | 2 | 0.149 | |
| negative regulation of protein sumoylation | GO:0033234 | 5 | 0.147 | |
| peripheral nervous system development | GO:0007422 | 2 | 0.146 | |
| negative regulation of phosphorus metabolic process | GO:0010563 | 267 | 0.146 | |
| determination of adult lifespan | GO:0008340 | 2 | 0.146 | |
| positive regulation of hormone secretion | GO:0046887 | 25 | 0.146 | |
| regulation of purine nucleotide metabolic process | GO:1900542 | 264 | 0.143 | |
| calcium ion transport | GO:0006816 | 147 | 0.141 | Human |
| regulation of ras protein signal transduction | GO:0046578 | 155 | 0.139 | |
| head development | GO:0060322 | 108 | 0.137 | |
| response to hormone | GO:0009725 | 175 | 0.136 | |
| heart morphogenesis | GO:0003007 | 48 | 0.134 | |
| muscle structure development | GO:0061061 | 98 | 0.134 | |
| protein processing | GO:0016485 | 226 | 0.131 | |
| positive regulation of gtp catabolic process | GO:0033126 | 166 | 0.131 | |
| negative regulation of protein modification by small protein conjugation or removal | GO:1903321 | 41 | 0.130 | |
| cellular response to peptide hormone stimulus | GO:0071375 | 56 | 0.130 | |
| regulation of cation channel activity | GO:2001257 | 33 | 0.129 | Human |
| oocyte differentiation | GO:0009994 | 2 | 0.126 | |
| regulation of ion transport | GO:0043269 | 189 | 0.126 | Human |
| regulation of ion transmembrane transporter activity | GO:0032412 | 72 | 0.125 | Human |
| cellular amino acid metabolic process | GO:0006520 | 116 | 0.125 | |
| regulation of anatomical structure morphogenesis | GO:0022603 | 286 | 0.124 | |
| oxidation reduction process | GO:0055114 | 396 | 0.124 | |
| cellular response to peptide | GO:1901653 | 59 | 0.123 | |
| nucleus localization | GO:0051647 | 1 | 0.122 | |
| glycosyl compound catabolic process | GO:1901658 | 413 | 0.120 | |
| g protein coupled receptor signaling pathway | GO:0007186 | 207 | 0.120 | |
| regulation of cell projection organization | GO:0031344 | 107 | 0.119 | |
| regulation of voltage gated calcium channel activity | GO:1901385 | 7 | 0.116 | Human |
| negative regulation of cellular protein metabolic process | GO:0032269 | 353 | 0.116 | |
| positive regulation of nucleotide metabolic process | GO:0045981 | 230 | 0.114 | |
| regulation of cell cycle process | GO:0010564 | 266 | 0.113 | |
| endomembrane system organization | GO:0010256 | 196 | 0.112 | |
| response to peptide | GO:1901652 | 65 | 0.112 | |
| single organism membrane organization | GO:0044802 | 268 | 0.110 | |
| hexose transport | GO:0008645 | 30 | 0.110 | |
| regulation of protein complex assembly | GO:0043254 | 147 | 0.108 | |
| cellular ketone metabolic process | GO:0042180 | 80 | 0.107 | |
| establishment of organelle localization | GO:0051656 | 59 | 0.107 | |
| regulation of actin cytoskeleton organization | GO:0032956 | 116 | 0.107 | |
| positive regulation of cellular component organization | GO:0051130 | 376 | 0.105 | |
| system process | GO:0003008 | 349 | 0.104 | Human |
| hemostasis | GO:0007599 | 76 | 0.103 | |
| positive regulation of cellular component biogenesis | GO:0044089 | 158 | 0.099 | |
| response to oxygen containing compound | GO:1901700 | 369 | 0.098 | |
| positive regulation of developmental process | GO:0051094 | 314 | 0.098 | |
| regulation of calcium ion transport | GO:0051924 | 79 | 0.097 | Human |
| carbohydrate transport | GO:0008643 | 37 | 0.094 | |
| cellular response to oxygen containing compound | GO:1901701 | 276 | 0.094 | |
| mitotic cell cycle process | GO:1903047 | 286 | 0.094 | |
| negative regulation of programmed cell death | GO:0043069 | 321 | 0.093 | |
| regulation of small gtpase mediated signal transduction | GO:0051056 | 156 | 0.092 | |
| negative regulation of phosphorylation | GO:0042326 | 174 | 0.092 | |
| gtp metabolic process | GO:0046039 | 239 | 0.091 | |
| establishment or maintenance of cell polarity | GO:0007163 | 31 | 0.091 | |
| regulation of glucose transport | GO:0010827 | 23 | 0.090 | |
| cell development | GO:0048468 | 328 | 0.090 | |
| negative regulation of protein metabolic process | GO:0051248 | 391 | 0.089 | |
| guanosine containing compound catabolic process | GO:1901069 | 239 | 0.089 | |
| cardiovascular system development | GO:0072358 | 262 | 0.088 | |
| homotypic cell cell adhesion | GO:0034109 | 47 | 0.088 | |
| single fertilization | GO:0007338 | 11 | 0.087 | |
| regulation of nucleotide metabolic process | GO:0006140 | 269 | 0.086 | |
| regulation of nucleocytoplasmic transport | GO:0046822 | 98 | 0.084 | |
| negative regulation of hydrolase activity | GO:0051346 | 182 | 0.084 | |
| transposition rna mediated | GO:0032197 | 0 | 0.084 | |
| epithelium development | GO:0060429 | 227 | 0.083 | |
| regulation of cellular response to stress | GO:0080135 | 244 | 0.082 | |
| vesicle mediated transport | GO:0016192 | 371 | 0.082 | |
| guanosine containing compound metabolic process | GO:1901068 | 244 | 0.082 | |
| regulation of transferase activity | GO:0051338 | 355 | 0.081 | |
| regulation of locomotion | GO:0040012 | 329 | 0.079 | |
| motor neuron axon guidance | GO:0008045 | 2 | 0.077 | |
| i kappab kinase nf kappab signaling | GO:0007249 | 166 | 0.077 | |
| positive regulation of catabolic process | GO:0009896 | 310 | 0.076 | |
| actin polymerization or depolymerization | GO:0008154 | 56 | 0.075 | |
| regulation of glucose import | GO:0046324 | 21 | 0.075 | |
| regulation of cell morphogenesis | GO:0022604 | 153 | 0.074 | |
| brain development | GO:0007420 | 97 | 0.074 | |
| embryo development ending in birth or egg hatching | GO:0009792 | 34 | 0.074 | |
| small gtpase mediated signal transduction | GO:0007264 | 78 | 0.074 | |
| dephosphorylation | GO:0016311 | 209 | 0.073 | |
| microtubule based process | GO:0007017 | 210 | 0.073 | |
| endocytosis | GO:0006897 | 159 | 0.073 | |
| generation of neurons | GO:0048699 | 152 | 0.073 | |
| peptide hormone secretion | GO:0030072 | 50 | 0.073 | |
| biological adhesion | GO:0022610 | 331 | 0.072 | |
| regulation of peptide secretion | GO:0002791 | 42 | 0.072 | |
| cellular cation homeostasis | GO:0030003 | 163 | 0.072 | |
| regulation of establishment of protein localization | GO:0070201 | 242 | 0.071 | |
| organelle assembly | GO:0070925 | 176 | 0.070 | |
| reproductive structure development | GO:0048608 | 55 | 0.070 | |
| generation of precursor metabolites and energy | GO:0006091 | 68 | 0.070 | |
| central nervous system development | GO:0007417 | 123 | 0.070 | |
| negative regulation of organelle organization | GO:0010639 | 126 | 0.070 | |
| positive regulation of gtpase activity | GO:0043547 | 166 | 0.069 | |
| ubiquitin dependent protein catabolic process | GO:0006511 | 206 | 0.069 | |
| divalent metal ion transport | GO:0070838 | 152 | 0.068 | Human |
| negative regulation of phosphate metabolic process | GO:0045936 | 267 | 0.068 | |
| negative regulation of locomotion | GO:0040013 | 118 | 0.068 | |
| negative regulation of ion transmembrane transport | GO:0034766 | 26 | 0.067 | Human |
| establishment or maintenance of bipolar cell polarity | GO:0061245 | 2 | 0.067 | |
| regulation of protein transport | GO:0051223 | 213 | 0.066 | |
| regulation of cellular amine metabolic process | GO:0033238 | 11 | 0.065 | |
| blood vessel morphogenesis | GO:0048514 | 162 | 0.065 | |
| organ morphogenesis | GO:0009887 | 147 | 0.064 | |
| protein sumoylation | GO:0016925 | 25 | 0.064 | |
| regulation of gtpase activity | GO:0043087 | 180 | 0.063 | |
| regulation of purine nucleotide catabolic process | GO:0033121 | 205 | 0.063 | |
| regulation of cell cycle | GO:0051726 | 393 | 0.063 | |
| protein modification by small protein conjugation | GO:0032446 | 342 | 0.063 | |
| calcium ion transmembrane transport | GO:0070588 | 76 | 0.063 | Human |
| response to organonitrogen compound | GO:0010243 | 156 | 0.062 | |
| striated muscle cell differentiation | GO:0051146 | 43 | 0.062 | |
| amine metabolic process | GO:0009308 | 44 | 0.061 | |
| eye development | GO:0001654 | 42 | 0.061 | |
| regulation of ion transmembrane transport | GO:0034765 | 132 | 0.060 | Human |
| mitotic cell cycle | GO:0000278 | 326 | 0.059 | |
| negative regulation of phosphatase activity | GO:0010923 | 61 | 0.058 | |
| monosaccharide transport | GO:0015749 | 32 | 0.058 | |
| negative regulation of transmembrane transport | GO:0034763 | 29 | 0.058 | Human |
| carbohydrate derivative biosynthetic process | GO:1901137 | 207 | 0.058 | |
| cellular ion homeostasis | GO:0006873 | 168 | 0.057 | |
| positive regulation of sequence specific dna binding transcription factor activity | GO:0051091 | 131 | 0.057 | |
| renal system development | GO:0072001 | 63 | 0.057 | |
| protein localization to nucleus | GO:0034504 | 136 | 0.056 | |
| regulation of protein modification by small protein conjugation or removal | GO:1903320 | 107 | 0.056 | |
| cilium morphogenesis | GO:0060271 | 75 | 0.056 | |
| cellular chemical homeostasis | GO:0055082 | 180 | 0.055 | |
| regulation of neuron migration | GO:2001222 | 3 | 0.055 | |
| regulation of protein polymerization | GO:0032271 | 63 | 0.055 | |
| protein stabilization | GO:0050821 | 64 | 0.053 | |
| regulation of cell migration | GO:0030334 | 289 | 0.053 | |
| regulation of cellular component movement | GO:0051270 | 334 | 0.052 | Human |
| regulation of transporter activity | GO:0032409 | 82 | 0.052 | Human |
| regulation of protein sumoylation | GO:0033233 | 13 | 0.051 | |
| cell cycle arrest | GO:0007050 | 71 | 0.050 | |
| regulation of cellular component size | GO:0032535 | 82 | 0.050 | |
| protein import into nucleus | GO:0006606 | 104 | 0.050 | |
| response to insulin | GO:0032868 | 45 | 0.050 | |
| cellular response to organonitrogen compound | GO:0071417 | 124 | 0.049 | |
| ribonucleoside triphosphate catabolic process | GO:0009203 | 391 | 0.049 | |
| cellular component assembly involved in morphogenesis | GO:0010927 | 73 | 0.048 | |
| nervous system development | GO:0007399 | 293 | 0.048 | |
| blood vessel endothelial cell migration | GO:0043534 | 42 | 0.048 | |
| mitotic cell cycle checkpoint | GO:0007093 | 68 | 0.047 | |
| cellular protein catabolic process | GO:0044257 | 261 | 0.047 | |
| asymmetric neuroblast division | GO:0055059 | 1 | 0.046 | |
| cell activation | GO:0001775 | 213 | 0.046 | |
| protein targeting to nucleus | GO:0044744 | 104 | 0.045 | |
| substantia nigra development | GO:0021762 | 45 | 0.045 | |
| platelet aggregation | GO:0070527 | 32 | 0.045 | |
| protein import | GO:0017038 | 130 | 0.045 | |
| cell type specific apoptotic process | GO:0097285 | 125 | 0.044 | |
| establishment of mitotic spindle orientation | GO:0000132 | 7 | 0.044 | |
| reproductive process | GO:0022414 | 106 | 0.044 | |
| regulation of cell differentiation | GO:0045595 | 393 | 0.044 | |
| cellular macromolecular complex assembly | GO:0034622 | 324 | 0.044 | |
| metal ion transport | GO:0030001 | 272 | 0.043 | Human |
| regulation of ras gtpase activity | GO:0032318 | 128 | 0.042 | |
| regulation of endocytosis | GO:0030100 | 72 | 0.042 | |
| regulation of jnk cascade | GO:0046328 | 73 | 0.042 | |
| positive regulation of cellular amino acid metabolic process | GO:0045764 | 3 | 0.041 | |
| cell fate determination | GO:0001709 | 3 | 0.041 | |
| negative regulation of transferase activity | GO:0051348 | 124 | 0.041 | |
| regulation of protein import into nucleus | GO:0042306 | 78 | 0.041 | |
| carbohydrate catabolic process | GO:0016052 | 36 | 0.040 | |
| negative regulation of cellular component organization | GO:0051129 | 235 | 0.040 | |
| regulation of nervous system development | GO:0051960 | 88 | 0.040 | |
| regulation of protein targeting | GO:1903533 | 91 | 0.040 | |
| regulation of nucleoside metabolic process | GO:0009118 | 209 | 0.039 | |
| regulation of cell motility | GO:2000145 | 299 | 0.039 | |
| mononuclear cell proliferation | GO:0032943 | 71 | 0.039 | |
| receptor mediated endocytosis | GO:0006898 | 84 | 0.038 | |
| peptidyl tyrosine modification | GO:0018212 | 170 | 0.038 | |
| blood vessel development | GO:0001568 | 172 | 0.038 | |
| regulation of lipase activity | GO:0060191 | 37 | 0.038 | |
| ruffle organization | GO:0031529 | 18 | 0.038 | |
| regulation of metal ion transport | GO:0010959 | 120 | 0.037 | Human |
| negative regulation of intracellular signal transduction | GO:1902532 | 183 | 0.037 | |
| negative regulation of cell cycle phase transition | GO:1901988 | 89 | 0.037 | |
| positive regulation of actin filament polymerization | GO:0030838 | 38 | 0.037 | |
| regulation of cellular ketone metabolic process | GO:0010565 | 50 | 0.036 | |
| regulation of meiotic cell cycle | GO:0051445 | 4 | 0.036 | |
| purine nucleotide biosynthetic process | GO:0006164 | 84 | 0.035 | |
| protein localization to membrane | GO:0072657 | 160 | 0.035 | |
| positive regulation of secretion | GO:0051047 | 116 | 0.035 | |
| positive regulation of cellular catabolic process | GO:0031331 | 284 | 0.035 | |
| regulation of reactive oxygen species metabolic process | GO:2000377 | 41 | 0.035 | |
| response to hypoxia | GO:0001666 | 96 | 0.035 | |
| macromolecule glycosylation | GO:0043413 | 63 | 0.035 | |
| tube morphogenesis | GO:0035239 | 95 | 0.035 | |
| neuron development | GO:0048666 | 113 | 0.034 | |
| regulation of protein stability | GO:0031647 | 87 | 0.034 | |
| neuron differentiation | GO:0030182 | 138 | 0.034 | |
| mitotic cell cycle phase transition | GO:0044772 | 162 | 0.034 | |
| establishment of protein localization to organelle | GO:0072594 | 172 | 0.034 | |
| cortical cytoskeleton organization | GO:0030865 | 9 | 0.033 | |
| positive regulation of ion transport | GO:0043270 | 87 | 0.033 | |
| regulation of growth | GO:0040008 | 165 | 0.033 | |
| negative regulation of kinase activity | GO:0033673 | 106 | 0.033 | |
| cell cycle phase transition | GO:0044770 | 173 | 0.033 | |
| actin filament bundle organization | GO:0061572 | 54 | 0.033 | |
| positive regulation of protein phosphorylation | GO:0001934 | 313 | 0.033 | |
| regulation of protein localization to nucleus | GO:1900180 | 85 | 0.033 | |
| positive regulation of purine nucleotide catabolic process | GO:0033123 | 185 | 0.033 | |
| regulation of transposition | GO:0010528 | 7 | 0.032 | |
| establishment of cell polarity | GO:0030010 | 22 | 0.032 | |
| cellular homeostasis | GO:0019725 | 196 | 0.032 | |
| negative regulation of protein maturation | GO:1903318 | 142 | 0.032 | |
| cellular response to dna damage stimulus | GO:0006974 | 379 | 0.032 | |
| negative regulation of cell cycle | GO:0045786 | 193 | 0.032 | |
| cellular response to external stimulus | GO:0071496 | 111 | 0.032 | |
| cranial nerve development | GO:0021545 | 4 | 0.032 | |
| regulation of vesicle mediated transport | GO:0060627 | 130 | 0.031 | |
| cellular component disassembly | GO:0022411 | 92 | 0.031 | |
| tube development | GO:0035295 | 125 | 0.031 | |
| retina development in camera type eye | GO:0060041 | 15 | 0.031 | |
| blood coagulation | GO:0007596 | 76 | 0.031 | |
| angiogenesis | GO:0001525 | 147 | 0.030 | |
| cellular component morphogenesis | GO:0032989 | 314 | 0.030 | |
| regulation of meiosis | GO:0040020 | 3 | 0.030 | |
| ribonucleotide biosynthetic process | GO:0009260 | 81 | 0.030 | |
| hair cell differentiation | GO:0035315 | 2 | 0.030 | |
| compound eye development | GO:0048749 | 1 | 0.030 | |
| single organism reproductive process | GO:0044702 | 98 | 0.029 | |
| regulation of neurotransmitter secretion | GO:0046928 | 3 | 0.029 | |
| nucleocytoplasmic transport | GO:0006913 | 176 | 0.029 | |
| renal tubule development | GO:0061326 | 19 | 0.029 | |
| morphogenesis of an epithelium | GO:0002009 | 60 | 0.029 | |
| cellular response to abiotic stimulus | GO:0071214 | 117 | 0.029 | |
| growth | GO:0040007 | 202 | 0.029 | |
| negative regulation of proteolysis | GO:0045861 | 132 | 0.028 | |
| regeneration | GO:0031099 | 4 | 0.028 | |
| positive regulation of cell differentiation | GO:0045597 | 211 | 0.028 | |
| thiamine transport | GO:0015888 | 3 | 0.028 | |
| regulation of protein kinase activity | GO:0045859 | 289 | 0.028 | |
| positive regulation of lipase activity | GO:0060193 | 28 | 0.028 | |
| microtubule cytoskeleton organization | GO:0000226 | 176 | 0.028 | |
| reproductive system development | GO:0061458 | 56 | 0.028 | |
| regulation of sequence specific dna binding transcription factor activity | GO:0051090 | 211 | 0.027 | |
| positive regulation of nervous system development | GO:0051962 | 54 | 0.027 | |
| cation transport | GO:0006812 | 331 | 0.027 | Human |
| platelet activation | GO:0030168 | 44 | 0.027 | |
| mammary gland morphogenesis | GO:0060443 | 2 | 0.027 | |
| nuclear import | GO:0051170 | 106 | 0.027 | |
| response to amino acid | GO:0043200 | 14 | 0.026 | |
| negative regulation of cation channel activity | GO:2001258 | 12 | 0.026 | Human |
| negative regulation of stress activated mapk cascade | GO:0032873 | 19 | 0.026 | |
| response to nitrogen compound | GO:1901698 | 184 | 0.026 | |
| copper ion homeostasis | GO:0055070 | 3 | 0.026 | |
| glycoprotein metabolic process | GO:0009100 | 110 | 0.026 | |
| actomyosin structure organization | GO:0031032 | 59 | 0.026 | |
| nerve development | GO:0021675 | 4 | 0.026 | |
| regulation of actin filament depolymerization | GO:0030834 | 10 | 0.026 | |
| pyrimidine containing compound transmembrane transport | GO:0072531 | 4 | 0.025 | |
| regulation of wnt signaling pathway | GO:0030111 | 123 | 0.025 | |
| regulation of peptidase activity | GO:0052547 | 180 | 0.025 | |
| ectodermal placode development | GO:0071696 | 1 | 0.025 | |
| mapk cascade | GO:0000165 | 288 | 0.025 | |
| single organism carbohydrate catabolic process | GO:0044724 | 33 | 0.025 | |
| regulation of cytoplasmic transport | GO:1903649 | 149 | 0.025 | |
| skin development | GO:0043588 | 76 | 0.025 | |
| peptidyl tyrosine phosphorylation | GO:0018108 | 170 | 0.025 | |
| response to abiotic stimulus | GO:0009628 | 336 | 0.025 | |
| positive regulation of intracellular transport | GO:0032388 | 104 | 0.025 | |
| negative regulation of calcium ion transmembrane transporter activity | GO:1901020 | 11 | 0.025 | Human |
| vacuole organization | GO:0007033 | 44 | 0.024 | |
| nuclear transport | GO:0051169 | 179 | 0.024 | |
| fertilization | GO:0009566 | 12 | 0.024 | |
| regulation of kinase activity | GO:0043549 | 314 | 0.024 | |
| chemical homeostasis | GO:0048878 | 306 | 0.024 | |
| regulation of dephosphorylation | GO:0035303 | 96 | 0.024 | |
| negative regulation of cytoskeleton organization | GO:0051494 | 45 | 0.024 | |
| somatic muscle development | GO:0007525 | 1 | 0.024 | |
| regulation of cell projection assembly | GO:0060491 | 47 | 0.024 | |
| peptide secretion | GO:0002790 | 51 | 0.024 | |
| developmental process involved in reproduction | GO:0003006 | 66 | 0.024 | |
| vesicle organization | GO:0016050 | 62 | 0.024 | |
| intracellular protein transport | GO:0006886 | 270 | 0.024 | |
| ribose phosphate biosynthetic process | GO:0046390 | 82 | 0.023 | |
| positive regulation of transferase activity | GO:0051347 | 227 | 0.023 | |
| response to peptide hormone | GO:0043434 | 61 | 0.023 | |
| nucleotide biosynthetic process | GO:0009165 | 109 | 0.023 | |
| macromolecular complex disassembly | GO:0032984 | 60 | 0.023 | |
| intrinsic apoptotic signaling pathway in response to dna damage | GO:0008630 | 50 | 0.022 | |
| establishment or maintenance of epithelial cell apical basal polarity | GO:0045197 | 1 | 0.022 | |
| response to oxidative stress | GO:0006979 | 121 | 0.022 | |
| myosin filament organization | GO:0031033 | 2 | 0.022 | |
| divalent inorganic cation transport | GO:0072511 | 158 | 0.022 | Human |
| cortical actin cytoskeleton organization | GO:0030866 | 9 | 0.022 | |
| regulation of nucleotide catabolic process | GO:0030811 | 205 | 0.022 | |
| positive regulation of organelle organization | GO:0010638 | 195 | 0.022 | |
| epithelial tube morphogenesis | GO:0060562 | 38 | 0.022 | |
| purine nucleoside monophosphate catabolic process | GO:0009128 | 158 | 0.022 | |
| positive regulation of axon extension | GO:0045773 | 4 | 0.022 | |
| activation of phospholipase d activity | GO:0031584 | 3 | 0.022 | |
| negative regulation of cellular amino acid metabolic process | GO:0045763 | 2 | 0.022 | |
| cellular response to extracellular stimulus | GO:0031668 | 72 | 0.022 | |
| negative regulation of ion transmembrane transporter activity | GO:0032413 | 19 | 0.021 | Human |
| receptor metabolic process | GO:0043112 | 81 | 0.021 | |
| multicellular organism reproduction | GO:0032504 | 42 | 0.021 | |
| response to nutrient levels | GO:0031667 | 81 | 0.021 | |
| neurogenesis | GO:0022008 | 169 | 0.021 | |
| negative regulation of multicellular organismal process | GO:0051241 | 317 | 0.021 | Human |
| positive regulation of cell proliferation | GO:0008284 | 301 | 0.021 | |
| stress activated protein kinase signaling cascade | GO:0031098 | 94 | 0.021 | |
| positive regulation of ras gtpase activity | GO:0032320 | 117 | 0.021 | |
| positive regulation of endocytosis | GO:0045807 | 42 | 0.021 | |
| gland development | GO:0048732 | 48 | 0.021 | |
| organelle fission | GO:0048285 | 149 | 0.021 | |
| axon cargo transport | GO:0008088 | 2 | 0.021 | |
| regulation of stress activated mapk cascade | GO:0032872 | 84 | 0.021 | |
| leukocyte proliferation | GO:0070661 | 74 | 0.020 | |
| cell growth | GO:0016049 | 160 | 0.020 | |
| cellular response to nutrient levels | GO:0031669 | 69 | 0.020 | |
| protein catabolic process | GO:0030163 | 325 | 0.020 | |
| coagulation | GO:0050817 | 78 | 0.020 | |
| asymmetric stem cell division | GO:0098722 | 1 | 0.020 | |
| cell part morphogenesis | GO:0032990 | 137 | 0.020 | |
| negative regulation of peptidase activity | GO:0010466 | 91 | 0.020 | |
| protein localization to plasma membrane | GO:0072659 | 93 | 0.020 | |
| carbohydrate metabolic process | GO:0005975 | 207 | 0.020 | |
| modification dependent macromolecule catabolic process | GO:0043632 | 212 | 0.020 | |
| regulation of proteolysis | GO:0030162 | 293 | 0.020 | |
| reactive oxygen species metabolic process | GO:0072593 | 75 | 0.019 | |
| single organism carbohydrate metabolic process | GO:0044723 | 193 | 0.019 | |
| single organism nuclear import | GO:1902593 | 104 | 0.019 | |
| adenylate cyclase activating adrenergic receptor signaling pathway | GO:0071880 | 3 | 0.019 | |
| negative regulation of protein phosphorylation | GO:0001933 | 140 | 0.019 | |
| cation homeostasis | GO:0055080 | 189 | 0.019 | |
| single organism cell adhesion | GO:0098602 | 179 | 0.019 | |
| ectodermal placode formation | GO:0060788 | 1 | 0.019 | |
| negative regulation of mitotic cell cycle | GO:0045930 | 102 | 0.019 | |
| regulation of cysteine type endopeptidase activity involved in apoptotic process | GO:0043281 | 116 | 0.019 | |
| establishment of tissue polarity | GO:0007164 | 3 | 0.018 | |
| receptor catabolic process | GO:0032801 | 11 | 0.018 | |
| regulation of gene expression epigenetic | GO:0040029 | 73 | 0.018 | |
| negative regulation of cellular amine metabolic process | GO:0033239 | 3 | 0.018 | |
| sensory organ development | GO:0007423 | 52 | 0.018 | |
| positive regulation of wound healing | GO:0090303 | 20 | 0.018 | |
| cellular amine metabolic process | GO:0044106 | 41 | 0.018 | |
| positive regulation of protein transport | GO:0051222 | 135 | 0.018 | |
| aging | GO:0007568 | 66 | 0.018 | |
| response to decreased oxygen levels | GO:0036293 | 96 | 0.018 | |
| osteoblast differentiation | GO:0001649 | 92 | 0.018 | |
| positive regulation of protein kinase activity | GO:0045860 | 190 | 0.018 | |
| ossification | GO:0001503 | 121 | 0.018 | |
| establishment of planar polarity | GO:0001736 | 3 | 0.018 | |
| regulation of methylation dependent chromatin silencing | GO:0090308 | 3 | 0.018 | |
| myosin filament assembly | GO:0031034 | 2 | 0.018 | |
| cellular carbohydrate metabolic process | GO:0044262 | 84 | 0.018 | |
| negative regulation of cell growth | GO:0030308 | 83 | 0.018 | |
| regulation of membrane potential | GO:0042391 | 95 | 0.018 | |
| positive regulation of i kappab kinase nf kappab signaling | GO:0043123 | 132 | 0.018 | |
| positive regulation of cell motility | GO:2000147 | 177 | 0.018 | |
| actin mediated cell contraction | GO:0070252 | 12 | 0.017 | Human |
| multicellular organismal signaling | GO:0035637 | 34 | 0.017 | Human |
| response to reactive oxygen species | GO:0000302 | 61 | 0.017 | |
| cellular response to nitrogen compound | GO:1901699 | 144 | 0.017 | |
| negative regulation of mapk cascade | GO:0043409 | 56 | 0.017 | |
| regulation of phosphatase activity | GO:0010921 | 81 | 0.017 | |
| positive regulation of neuron differentiation | GO:0045666 | 40 | 0.017 | |
| negative regulation of protein complex assembly | GO:0031333 | 43 | 0.017 | |
| regulation of peptidyl tyrosine phosphorylation | GO:0050730 | 108 | 0.017 | |
| response to wounding | GO:0009611 | 168 | 0.017 | |
| monocarboxylic acid metabolic process | GO:0032787 | 185 | 0.017 | |
| positive regulation of protein polymerization | GO:0032273 | 45 | 0.017 | |
| cytoskeleton dependent intracellular transport | GO:0030705 | 21 | 0.017 | |
| regulation of glial cell proliferation | GO:0060251 | 4 | 0.017 | |
| sex differentiation | GO:0007548 | 45 | 0.017 | |
| protein depolymerization | GO:0051261 | 30 | 0.017 | |
| epithelial cell differentiation | GO:0030855 | 141 | 0.017 | |
| urogenital system development | GO:0001655 | 65 | 0.016 | |
| positive regulation of osteoblast differentiation | GO:0045669 | 23 | 0.016 | |
| regulation of nucleotide biosynthetic process | GO:0030808 | 50 | 0.016 | |
| barbed end actin filament capping | GO:0051016 | 3 | 0.016 | |
| necrotic cell death | GO:0070265 | 21 | 0.016 | |
